OFFERING SEMAGLUTIDE & TIRZEPATIDE As many patients struggling with insulin resistance-related weight loss can attest, this recent discovery is a game changer
BPC-157 is incorporated alongside physiotherapy, nutrition, lifestyle optimization and recovery strategies to ensure safety, effectiveness and long-term health outcomes
Those are brand names what we prescribe is compounded semaglutide and tirzepatide, the same active medications behind them, dosed and supervised by our medical team
Key safety risks include hypoglycaemia when combined with insulin or sulphonylureas, gastrointestinal interactions, pancreatitis, gallbladder disease, and dehydration-related acute kidney injury
I promise to openly share the pros and cons of everything I experience